Premium Medical Imaging Ultrasound System Announced
By Medimaging International staff writers
Posted on 14 Aug 2017
Image: The Aixplorer Ultimate ultrasound system, which features ShearWave Elastography and UltraFast Doppler capabilities (Photo courtesy of SuperSonic Imagine).
A premium ultrasound system with new clinical innovations, such as a 200-times faster acquisition rate than existing systems, has been announced.
The system has a new architecture, a streamlined design, 4.5 times more computing power than previous versions, an improved user interface, and is easier to use especially for long working shifts.
The Aixplorer Ultimate premium ultrasound system was developed by SuperSonic Imagine (Aix, France). The system uses the company’s new UltraFast Needle PL.U.S technology for precise simultaneous visualization of anatomical structures and for the trajectory of biopsy needles.
The Aixplorer Ultimate also features ShearWave Elastography (SWE), ultraFast Doppler with both Color Doppler and Pulsed Doppler in a single sweep, Angio PL.U.S for imaging micro-vascularization, and TriVu that combines three types of diagnostic information in a single exam. The system provides reliable and rapid access to diagnostic information for the assessment chronic liver disease, breast cancer, prostate cancers, and other diseases, and can also be used for pediatric and vascular examinations. SWE is used for Musculoskeletal (MSK) imaging to view muscles, tendons, ligaments and joints, for diagnosing and monitoring conditions such as tendinopathy.
Co-Founder, and CIO at SuperSonic Imagine, Jacques Souquet, said, “Aixplorer Ultimate is the result of 8 years of research and development. This is a much more reliable, faster and innovative ultrasound system, designed to meet new imaging needs when screening, diagnosing and monitoring major diseases. Discussed in more than 400 publications, the SWE technology employed in this system has demonstrated its clinical advantages associated with the detection and characterization of many different diseases across a broad spectrum of applications."